AIDX
20/20 Biolabs Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.53
+0.05 ▲ +2.02%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$2.52
-0.01 ▼ -0.45%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 64.32% | Shs Outstand | 0.00B | Perf Week | -9.64% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | - |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 6.04% | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.24 | Perf Half Y | - |
| Sales | - | P/B | 203.05 | EPS next 5Y | - | ROA | - | Short Interest | 0.11M | Perf YTD | -89.39% |
| Book/sh | 0.01 | P/C | 10.92 | EPS past 3/5Y | - -17.86% | ROE | - | 52W High | -94.94% ($50.00) | Perf Year | - |
| Cash/sh | 0.23 | P/FCF | - | Sales past 3/5Y | -43.32% 43.47% | ROIC | - | 52W Low | 4.55% ($2.42) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 4.55% | Gross Margin | - | Volatility(W/M) | 14.3% - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.62 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.76 | EPS Q/Q | 59.52% | Profit Margin | - | RSI (14) | 2.19 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.79 | Sales Q/Q | -0.33% | SMA20 | -56.76% ($5.85) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 10.55 | Earnings | - | SMA50 | -56.76% ($5.85) | Rel Volume | 0.56 | Prev Close | $2.48 |
| Employees | 20 | LT Debt/Eq | 9 | EPS/Sales Surpr. | - | SMA200 | -56.76% ($5.85) | Avg Volume(3M) | 0.44M | Price | $2.53 |
| IPO | 2026/2/19 | Option/Short | No/Yes | Trades | 760 | Volume | 245,395 | Change | 2.02% |
뉴스 로딩 중...